Astrana Health upgraded by Truist with a new price target
$ASTH
Professional Services
Consumer Discretionary
Truist upgraded Astrana Health from Hold to Buy and set a new price target of $50.00 from $44.00 previously
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/14/2024 | $66.00 | Buy | TD Cowen |
| 10/11/2024 | Sector Weight | KeyBanc Capital Markets | |
| 7/11/2024 | $44.00 → $50.00 | Hold → Buy | Truist |
| 5/30/2024 | $54.00 | Outperform | Robert W. Baird |
ALHAMBRA, Calif., Nov. 21, 2024 /PRNewswire/ -- Astrana Health, Inc. ("Astrana"), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, is proud to announce that eight of its affiliates have been recognized as Elite status recipients in the 2024 Standards of Excellence™ (SOE®) survey by America's Physician Groups (APG). This annual comprehensive survey is administered by APG to evaluate which physician groups are best positioned to provide coordinated, patient-centered, and cost-effective care.
ALHAMBRA, Calif., Nov. 8, 2024 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that it and its affiliated professional entities have entered into a definitive agreement to acquire Prospect Health ("Prospect"), which consists of certain businesses and assets relating to Prospect Health System, including its California licensed health care service plan (Prospect Health Plan), medical groups in California, Texas, Arizona and Rhode Island (Pro
Company to Host Conference Call on Thursday, November 7, 2024, at 2:30 p.m. PT/5:30 p.m. ET ALHAMBRA, Calif., Nov. 7, 2024 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced its consolidated financial results for the third quarter ended September 30, 2024. "Astrana's strong third quarter continues to reflect the outcomes we are
ALHAMBRA, Calif., Nov. 8, 2024 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that it and its affiliated professional entities have entered into a definitive agreement to acquire Prospect Health ("Prospect"), which consists of certain businesses and assets relating to Prospect Health System, including its California licensed health care service plan (Prospect Health Plan), medical groups in California, Texas, Arizona and Rhode Island (Pro
Company to Host Conference Call on Thursday, November 7, 2024, at 2:30 p.m. PT/5:30 p.m. ET ALHAMBRA, Calif., Nov. 7, 2024 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced its consolidated financial results for the third quarter ended September 30, 2024. "Astrana's strong third quarter continues to reflect the outcomes we are
ALHAMBRA, Calif., Oct. 23, 2024 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that it will release financial results for the third quarter ended September 30, 2024, after the close of the stock market on Thursday, November 7, 2024. The Company will discuss those results on a conference call at 2:30 p.m. PT/5:30 p.m. ET that same day.
4 - Astrana Health, Inc. (0001083446) (Issuer)
4 - Astrana Health, Inc. (0001083446) (Issuer)
4 - Astrana Health, Inc. (0001083446) (Issuer)
Expands Payer-Agnostic Care Delivery Capabilities Serving Over 129,000 Beneficiaries Across 17 States
Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, Anthem Blue Cross, one of California's largest health insurers, and Allied Pacific IPA, part of Astrana Health, a leading independent physician association serving the California community since 1992, today announced a new partnership aimed at improving access to high-quality healthcare for their shared members.This partnership underscores both organizations' commitment to increasing access to care by addressing social and health i
TD Cowen initiated coverage of Astrana Health with a rating of Buy and set a new price target of $66.00
KeyBanc Capital Markets initiated coverage of Astrana Health with a rating of Sector Weight
Truist upgraded Astrana Health from Hold to Buy and set a new price target of $50.00 from $44.00 previously
8-K - Astrana Health, Inc. (0001083446) (Filer)
8-K - Astrana Health, Inc. (0001083446) (Filer)
10-Q - Astrana Health, Inc. (0001083446) (Filer)